Regulation of arachidonic acid availability for eicosanoid production

Biochemistry and Cell Biology

Volumn 82, Issue 1, 2004, Pages 1-17

  Leslie, Christina C ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Arachidonic acid; Eicosanoid; Phospholipase A2; Phospholipid

Indexed keywords

CELLS; ENZYMES; ESTERIFICATION; METABOLITES; PHOSPHOLIPIDS;

ARACHIDONIC ACID; BIOACTIVE MEDIATORS; PATHOPHYSIOLOGICAL PROCESSES;

BIOCHEMISTRY;

ACYLTRANSFERASE; ARACHIDONIC ACID; ICOSANOID; PHOSPHOLIPASE A2;

CELL TYPE; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME REGULATION; ESTERIFICATION; FATTY ACID SYNTHESIS; HUMAN; KNOCKOUT MOUSE; LIPID HYDROLYSIS; MAMMAL CELL; MEDIATOR; METABOLITE; NONHUMAN; OXYGENATION; PROTEIN FUNCTION; SHORT SURVEY;

ACYLTRANSFERASES; ANIMALS; ARACHIDONIC ACID; EICOSANOIDS; MICE; MICE, KNOCKOUT; PHOSPHOLIPASES A; PHOSPHOLIPIDS;

MAMMALIA;

EID: 1842556175     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o03-080     Document Type: Short Survey

References (198)

1. 2 by bromoenol lactone and trifluoromethyl ketones. J. Biol. Chem. 270: 445-450.
2. Alonso, F., Henson, P.M., and Leslie, C.C. 1986. A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine. Biochim. Biophys. Acta, 878: 273-280.
3. 2s regulating NF-κB activation in response to tumor-necrosis factor-α and interleukin-1β. J. Biol. Chem. 276: 35 344 - 35 351.
4. 2 modulates tumor necrosis factor-α- and interleukin-1β-induced NF-κB activation. J. Biol. Chem. 276: 30 527 - 30 536.
5. 2, which undergoes proteolytic inactivation. J. Biol. Chem. 273: 13 870 - 13 877.
6. 1 macrophages. J. Biol. Chem. 271: 32 381 - 32 384.
7. 2-derived hydroperoxyeicosatetraenoic acid. J. Immunol. 171: 989-994.
8. 2 in caveolin-enriched granules in activated P388D1 macrophage-like cells. J. Biol. Chem. 278: 48 059 - 48 065.
9. 2 enzyme present in P388D1 macrophages. J. Biol. Chem. 271: 6758-6765.
10. 1 macrophages. Proc. Natl. Acad. Sci. U.S.A. 92: 8527-8531.
11. 2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages. J. Biol. Chem. 272: 29 317 - 29 321.
12. 2. Ann. Rev. Pharmacol. Toxicol. 39: 175-189.
13. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J. Biol. Chem. 269: 15 625 - 15 630.
14. 2-paradigm. Chem. Rev. 101: 2613-2654.
15. Beutler, B., and Rietschel, E.T. 2003. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3: 169-176.
16. 2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 275: 3179-3191.
17. 2 for membranes with anionic phospholipids. J. Biol. Chem. 277: 48 523 - 48 534.
18. 2 in remodeling and increased susceptibility of proliferating T cells to CoA-independent transacyclase inhibitor-induced apoptosis. J. Biol. Chem. 276: 17 568 - 17 575.
19. Bonner, J.C., Rice, A.B., Ingram, J.L., Moomaw, C.R., Nyska, A., Bradbury, A., Sessoms, A.R., Chulada, P.C., Morgan, D.L., Zeldin, D.C. et al. 2002. Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am. J. Pathol. 161: 459-470.
20. 2) function: insights from the knockout mouse. Adv. Exp. Med. Biol. 507: 25-31.
21. 2. Nature (London), 390: 622-625.
22. Brash, A.R. 1999. Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J. Biol. Chem. 274: 23 679 - 23 682.
23. Brash, A.R. 2001. Arachidonic acid as a bioactive molecule. J. Clin. Invest. 107: 1339-1345.
24. Cao, Y., Traer, E., Zimmerman, G.A., McIntyre, T.M., and Prescott, S.M. 1998. Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4). Genomics, 49: 327-330.
25. 2 is required for human monocyte chemotaxis to monocyte chemoattractant protein 1. J. Immunol. 167: 3414-3421.
26. 2 with membrane in the macrophage cell line, RAW 264.7. J. Biol. Chem. 265: 5409-5413.
27. Chilton, F.H. 1989. Potential phospholipid source(s) of arachidonate used for the synthesis of leukotrienes by the human neutrophil. Biochem. J. 285: 317-333.
28. Chilton, F.H., and Cornell, T.R. 1988. 1-ether-linked phosphoglycerides. Major endogenous sources of arachidonate in the human neutrophil. J. Biol. Chem. 263: 5260-5265.
29. Chilton, F.H., and Murphy, R.C. 1986. Remodeling of arachidonate- containing phosphoglycerides within the human neutrophil. J. Biol. Chem. 261: 7771-7777.
30. Cho, H.P., Nakamura, M., and Clarke, S.D. 1999a. Cloning, expression, and fatty acid regulation of the human delta-5 desaturase. J. Biol. Chem. 274: 37 335 - 37 339.
31. Cho, H.P., Nakamura, M.T., and Clarke, S.D. 1999b. Cloning, expression, and nutritional regulation of the mammalian Delta-6 desaturase. J. Biol. Chem. 274: 471-477.
32. 2 from the human monocytic cell line U937. Proc. Natl. Acad. Sci. U.S.A. 87: 7708-7712.
33. 2+-dependent translocation domain with homology to PKC and GAP. Cell, 65: 1043-1051.
34. 2. J. Lipid Mediat. Cell Signal, 12: 83-117.
35. 2 promotes scavenger receptor class B type I interaction and accelerates HDL catabolism. J. Lipid Res. 41: 1849-1857.
36. 2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J. Biol. Chem. 277: 5061-5073.
37. Diaz, B.L., Fujishima, H., Sapirstein, A., Bonventre, J.V., and Arm, J.P. 2002. Participation of cytosolic phospholipase A2 in eicosanoid generation by mouse bone marrow-derived mast cells. Adv. Exp. Med. Biol. 507: 41-46.
38. 2 from human monocytic leukemic U937 cells. J. Biol. Chem. 265: 14 654 - 14 661.
39. Elliott, A.C. 2001. Recent developments in non-excitable cell calcium entry. Cell. Calcium, 30: 73-93.
40. Evans, J.F. 2002. Cysteinyl leukotriene receptors. Prostaglandins Other Lipid Mediat. 68-69: 587-597.
41. 2 translocation to internal membranes. J. Biol. Chem. 276: 30 150 - 30 160.
42. 2 against Gram-positive bacteria. J. Clin. Invest. 103: 715-721.
43. 2. FEBS Lett. 531: 7-11.
44. Fujino, T., and Yamamoto, T. 1992. Cloning and functional expression of a novel long-chain acyl-CoA synthetase expressed in brain. J. Biochem. (Tokyo), 111: 197-203.
45. Fujino, T., Kang, M.J., Suzuki, H., Iijima, H., and Yamamoto, T. 1996. Molecular characterization and expression of rat acyl-CoA synthetase 3. J. Biol. Chem. 271: 16 748 - 16 752.
46. 2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells. Proc. Natl. Acad. Sci. U.S.A. 96: 4803-4807.
47. Funk, C.D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science (Washington, D.C.), 294: 1871-1875.
48. 2 in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin. Biochemistry, 41: 4911-4920.
49. 2α blocks arachidonic acid release in a variety of mammalian cells. Biochim. Biophys. Acta, 1513: 160-166.
50. 2 production by lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 30: 91-100.
51. 2 activation. J. Leukoc. Biol. 65: 330-336.
52. 2. J. Cell Biol. 145: 1219-1232.
53. 2 regulation. J. Biol. Chem. 275: 20 146 - 20 156.
54. 2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J. Biol. Chem. 270: 15 359 - 15 367.
55. Goldstein, R.H., and Polgar, P. 1982. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J. Biol. Chem. 257: 8630-8633.
56. Goldstein, R.H., Fine, A., Farnsworth, L.J., Poliks, C., and Polgar, P. 1990. Phorbol ester-induced inhibition of collagen accumulation by human lung fibroblasts. J. Biol. Chem. 265: 13 623 - 13 628.
57. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J. Clin. Invest. 97: 2233-2241.
58. 2 in rat renal mesangial cells. J. Biol. Chem. 263: 16 645 - 16 651.
59. 2 from rat kidney activated at physiological calcium concentrations. Biochem. J. 271: 37-43.
60. 2. J. Biol. Chem. 270: 14 855 - 14 858.
61. Gross, G.A., Imamura, T., Luedke, C., Vogt, S.K., Olson, L.M., Nelson, D.M., Sadovsky, Y., and Muglia, L.J. 1998. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc. Natl. Acad. Sci. U.S.A. 95: 11 875 - 11 879.
62. 2. J. Biol. Chem. 274: 11 881 - 11 888.
63. 2 α activity that is responsible for arachidonic acid release. J. Biol. Chem. 278: 24 153 - 24 163.
64. 2. Prostaglandins Other Lipid Mediat. 68-69: 71-82.
65. 2 induced prominent release of arachidonic acid from human myeloid leukemia cells. J. Biol. Chem. 274: 34 203 - 34 211.
66. 2 is linked to macrophage foam cell formation. J. Biol. Chem. 277: 29 116 - 29 124.
67. 2 promotes striated muscle growth. Nat. Med. 9: 944-951.
68. 2. J. Biol. Chem. 268: 9892-9900.
69. 2 during rabbit myocardial ischemia which is highly selective for plasmalogen substrate. J. Biol. Chem. 266: 5629-5633.
70. 2. J. Biol. Chem. 266: 7227-7232.
71. 2 by MNK1-related protein kinases. J. Biol. Chem. 275: 37 542 - 37 551.
72. 2α-deficient mice are resistant to collagen-induced arthritis. J. Exp. Med. 197: 1297-1302.
73. 2. J. Biol. Chem. 274: 5163-5169.
74. Hizaki, H., Segi, E., Sugimoto, Y., Hirose, M., Saji, T., Ushikubi, F., Matsuoka, T., Noda, Y., Tanaka, T., Yoshida, N., et al. 1999. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2. Proc. Natl. Acad. Sci. U.S.A. 96: 10 501 - 10 506.
75. 2. Biochemistry, 35: 3712-3721.
76. Hume, D.A., Ross, I.L., Himes, S.R., Sasmono, R.T., Wells, C.A., and Ravasi, T. 2002. The mononuclear phagocyte system revisited. J. Leukocyte Biol. 72: 621-627.
77. Hwang, D.H. 1982. Characteristics of the formation of the platelet lipoxygenase product from endogenous arachidonic acid. Lipids, 17: 845-847.
78. Inoue, M., Murase, S., and Okuyama, H. 1984. Acyl coenzyme A:phospholipid acyltransferases in porcine platelets discriminate between omega-3 and omega-6 unsaturated fatty acids. Arch. Biochem. Biophys. 231: 29-37.
79. Irvin, C.G., Tu, Y.P., Sheller, J.R., and Funk, C.D. 1997. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am. J. Physiol. 272: L1053-L1058.
80. 2. Arterioscler. Thromb. Vasc. Biol. 19: 1284-1290.
81. 2β. implications for structure and function. J. Biol. Chem. 276: 7129-7135.
82. 2γ, as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells. J. Biol. Chem. 277: 32 807 - 32 814.
83. Keerthisingam, C.B., Jenkins, R.G., Harrison, N.K., Hernandez-Rodriguez, N.A., Booth, H., Laurent, G.J., Hart, S.L., Foster, M.L., and McAnulty, R.J. 2001. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 158: 1411-1422.
84. 2 gene in inbred mouse strains. J. Biol. Chem. 270: 22 378 - 22 385.
85. Kennedy, C.R., Zhang, Y., Brandon, S., Guan, Y., Coffee, K., Funk, C.D., Magnuson, M.A., Oates, J.A., Breyer, M.D., and Breyer, R.M. 1999. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat. Med. 5: 217-220.
86. 2 internalization and degradation. J. Biol. Chem. 276: 11 126 - 11 134.
87. 2 activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J. Exp. Med. 196: 655-665.
88. 2. J. Biol. Chem. 277: 36 479 - 36 488.
89. 2 on cell membranes. Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme. J. Biol. Chem. 273: 32 142 - 32 153.
90. 2. J. Biol. Chem. 277: 5849-5857.
91. 2 against Staphylococcus aureus. J. Biol. Chem. 277: 47 636 - 47 644.
92. Korn, J.H., Halushka, P.V., and LeRoy, E.C. 1980. Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J. Clin. Invest. 65: 543-554.
93. Kramer, R.M., and Deykin, D. 1983. Arachidonoyl transacylase in human platelets. Coenzyme A-independent transfer of arachidonate from phosphatidylcholine to lysoplasmenylethanolamine. J. Biol. Chem. 258: 13 806 - 13 811.
94. 2 is a 100-kDa protein in human monoblast U937 cells. J. Biol. Chem. 266: 5268-5272.
95. 2 enzymes. Prostaglandins Other Lipid Mediat. 68-69: 3-58.
96. 2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. J. Biol. Chem. 273: 1733-1740.
97. 2. J. Immunol. 165: 4024-4031.
98. 2 against Staphylococcus aureus. J. Immunol. 162: 7402-7408.
99. 2 to Escherichia coli infection. Infect. Immun. 68: 87-92.
100. 2 (88kDa) in immature and mature myeloid cells and its role in leukotriene synthesis in human granulocytes. FEBS Lett. 434: 295-299.
101. 2 and their effect on enzyme activity. J. Biol. Chem. 273: 207-214.
102. Lauber, K., Bohn, E., Krober, S.M., Xiao, Y.J., Blumenthal, S.G., Lindemann, R.K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., et al. 2003. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell, 113: 717-730.
103. 2. J. Biol. Chem. 268: 20 713 - 20 716.
104. 2 that exhibits lysophospholipase activity. J. Biol. Chem. 266: 11 366 - 11 371.
105. 2. J. Biol. Chem. 272: 16 709 - 16 712.
106. Leslie, C.C., and Detty, D.M. 1986. Arachidonic acid turnover in response to lipopolysaccharide and opsonized zymosan in human monocyte-derived macrophages. Biochem. J. 236: 251-259.
107. 2 from a macrophage cell line, RAW 264.7. Biochim. Biophys. Acta, 963: 476-492.
108. Lim, H., Paria, B.C., Das, S.K., Dinchuk, J.E., Langenbach, R., Trzaskos, J.M., and Dey, S.K. 1997. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell, 91: 197-208.
109. Lim, H., Gupta, R.A., Ma, W.G., Paria, B.C., Moller, D.E., Morrow, J.D., DuBois, R.N., Trzaskos, J.M., and Dey, S.K. 1999. Cyclooxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev. 13: 1561-1574.
110. 2 is phosphorylated and activated by MAP kinase. Cell, 72: 269-278.
111. 2 by methyl arachidonyl fluorophosphonate. Biochim. Biophys. Acta, 1302: 55-60.
112. 2. Prog. Nucleic Acid Res. Mol. Biol. 67: 1-33.
113. 2 gene on chromosome 22q13.1. J. Biol. Chem. 274: 9607-9616.
114. 2β. J. Biol. Chem. 276: 13 198 - 13 208.
115. 2β in INS-1 insulinoma cells. Am. J. Physiol. Endocrinol. Metab. 282: E820-E833.
116. 2. J. Biol. Chem. 275: 9937-9945.
117. 2β, precipitating ventricular tachyarrhythmias in transgenic mice: rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition. J. Biol. Chem. 278: 22 231 - 22 236.
118. McAnulty, R.J., Hernandez-Rodriguez, N.A., Mutsaers, S.E., Coker, R.K., and Laurent, G.J. 1997. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-β isoforms on fibroblast cell cultures. Biochem. J. 321: 639-643.
119. McArthur, M.J., Atshaves, B.P., Frolov, A., Foxworth, W.D., Kier, A.B., and Schroeder, F. 1999. Cellular uptake and intracellular trafficking of long chain fatty acids. J. Lipid Res. 40: 1371-1383.
120. Mosser, D.M. 2003. The many faces of macrophage activation. J. Leukoc. Biol. 73: 209-212.
121. Mueller, H.W., O'Flaherty, J.T., Greene, D.G., Samuel, M.P., and Wykle, R.L. 1984. 1-O-alkyl-linked glycerophospholipids of human neutrophils: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. J. Lipid Res. 25: 383-388.
122. 2-independent cysteinyl leukotriene synthesis in human eosinophils. J. Biol. Chem. 278: 38 813 - 38 820.
123. 2s. Adv. Immunol. 77: 163-194.
124. 2s in regulating arachidonic acid release. J. Biol. Chem. 273: 14 411 - 14 423.
125. 2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274: 3103-3115.
126. 2 with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid-biosynthetic pathway. J. Biol. Chem. 274: 29 927 - 29 936.
127. 2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275: 32 783 - 32 792.
128. 2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 276: 10 083 - 10 096.
129. 2. J. Biol. Chem. 277: 19 145 - 19 155.
130. 2. J. Biol. Chem. 276: 39 653 - 39 660.
131. 2. Nat. Immunol. 1: 42-46.
132. 2 in bleomycin-induced pulmonary fibrosis. Nat. Med. 8: 480-484.
133. Nakamura, M.T., and Nara, T.Y. 2003. Essential fatty acid synthesis and its regulation in mammals. Prostaglandins Leukotrienes Essen. Fatty Acids, 68: 145-150.
134. 2 in the production of lipid mediators and histamine release in mouse bone-marrow-derived mast cells. Biochem. J. 352(Pt. 2): 311-317.
135. Narumiya, S., and FitzGerald, G.A. 2001. Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 108: 25-30.
136. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268: 1960-1964.
137. 2 in inflammatory diseases and trauma. Biochim. Biophys. Acta, 1488: 83-90.
138. 2α, pyrrophenone. Biochem. J. 363: 727-735.
139. 2 and protein kinase C-dependent phosphorylation of the alpha-subunit. J. Biol. Chem. 274: 2000-2008.
140. 2. J. Biol. Chem. 274: 14 979 - 14 987.
141. Peters-Golden, M., and Brock, T.G. 2001. Intracellular compartmentalization of leukotriene synthesis: unexpected nuclear secrets. FEBS Lett. 487: 323-326.
142. Peters-Golden, M., Bailie, M., Marshall, T., Wilke, C., Phan, S.H., Toews, G.B., and Moore, B.B. 2002. Protection from pulmonary fibrosis in leukotriene-deficient mice. Am. J. Respir. Crit. Care Med. 165: 229-235.
143. 2. J. Biol. Chem. 274: 8823-8831.
144. Pressman, B.C. 1976. Biological applications of ionophores. Ann. Rev. Biochem. 45: 501-530.
145. 2: preferential hydrolysis of acute phase HDL. J. Lipid Res. 39: 2150-2160.
146. 2. Lab. Invest. 81: 757-765.
147. 2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears. Infect Immun. 66: 2791-2797.
148. Ramanadham, S., Gross, R.W., Han, X., and Turk, J. 1993. Inhibition of arachidonate release by secretagogue-stimulated pancreatic islets suppresses both insulin secretion and the rise in β-cell cytosolic calcium ion concentration. Biochemistry, 32: 337-346.
149. 2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells. J. Biol. Chem. 274: 13 915 - 13 927.
150. 2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J. Biol. Chem. 269: 15 619 - 15 624.
151. 2 as defined by gene knockouts. Biochim. Biophys. Acta, 1488: 139-148.
152. 2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270: 30 749 - 30 754.
153. Scott, W.A., Zrike, J.M., Hamill, A.L., Kempe, J., and Cohn, Z.A. 1980. Regulation of arachidonic acid metabolites in macrophages. J. Exp. Med. 152: 324-335.
154. 2-derived arachidonic acid is essential for endothelium-dependent relaxation by acetylcholine. J. Pharmacol. Exper. Therap. 302: 918-923.
155. Selman, M., King, T.E., and Pardo, A. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134: 136-151.
156. 2. J. Med. Chem. 43: 1041-1044.
157. 2. J. Biol. Chem. 269: 23 250 - 23 254.
158. 2 and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. Biochem. Biophys. Res. Commun. 271: 812-817.
159. 2s. J. Biol. Chem. 274: 12 263 - 12 268.
160. 2. J. Biol. Chem. 277: 48 535 - 48 549.
161. 2 enzymes: classification and characterization. Biochim. Biophys. Acta, 1488: 1-19.
162. 2+ entry. J. Biol. Chem. 278: 11 909 - 11 915.
163. Smith, W.L., and Langenbach, R. 2001. Why there are two cyclooxygenase isozymes. J. Clin. Invest. 107: 1491-1495.
164. Smith, W.L., DeWirt, D.L., and Garavito, R.M. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Ann. Rev. Biochem. 69: 145-182.
165. 2-β. J. Biol. Chem. 274: 17 063 - 17 067.
166. 2γ. J. Biol. Chem. 277: 29 526 - 29 536.
167. 2. Biochemistry, 32: 5935-5940.
168. Sugimoto, Y., Yamasaki, A., Segi, E., Tsuboi, K., Aze, Y., Nishimura, T., Oida, H., Yoshida, N., Tanaka, T., Katsuyama, M., et al. 1997. Failure of parturition in mice lacking the prostaglandin F receptor. Science (Washington, D.C.), 277: 681-683.
169. Sugiura, T., Masuzawa, Y., Nakagaw, Y., and Waku, K. 1987. Transacylation of lyso platelet-activating factor and other lysophospholipids by macrophage microsomes. Distinct donor and acceptor selectivities. J. Biol. Chem. 262: 1199-1205.
170. Suzuki, H., Kawarabayasi, Y., Kondo, J., Abe, T., Nishikawa, K., Kimura, S., Hashimoto, T., and Yamamoto, T. 1990. Structure and regulation of rat long-chain acyl-CoA synthetase. J. Biol. Chem. 265: 8681-8685.
171. 2 contains eight ankyrin motifs. J. Biol. Chem. 272: 8567-8575.
172. Tessner, T.G., Greene, D.G., and Wykle, R.L. 1990. Selective deacylation of arachidonate-containing ethanolamine-linked phosphoglycerides in stimulated human neutrophils. J. Biol. Chem. 265: 21 032 - 21 038.
173. 2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice. Arterioscler. Thromb. Vasc. Biol. 22: 1213-1218.
174. Tilley, S.L., Coffman, T.M., and Koller, B.H. 2001. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108: 15-23.
175. 4 receptors. Prostaglandins Other Lipid Mediat. 68-69: 575-585.
176. 2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1: 739-754.
177. Tsuboi, K., Sugimoto, Y., and Ichikawa, A. 2002. Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat. 68-69: 535-556.
178. Uemura, Y., Lee, T.-C., and Snyder, F. 1991. A coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodeling pathway. J. Biol. Chem. 266: 8268-8272.
179. 2. J. Biol. Chem. 273: 21 926 - 21 932.
180. 2α as revealed by gene-targeted mice. Prostaglandin Other Lipid Mediat. 68-69: 59-69.
181. 2 in allergic response and parturition. Nature (London), 390: 618-622.
182. 2 and their receptors and binding proteins. Biochim. Biophys. Acta, 1488: 59-70.
183. 2? Biochimie, 82: 815-831.
184. 2. J. Clin. Invest. 97: 250-257.
185. 2. J. Clin. Invest. 102: 633-638.
186. Winchester, S.K., Imamura, T., Gross, G.A., Muglia, L.M., Vogt, S.K., Wright, J., Watanabe, K., Tai, H.H., and Muglia, L.J. 2002. Coordinate regulation of prostaglandin metabolism for induction of parturition in mice. Endocrinology, 143: 2593-2598.
187. Winkler, J.D., Sung, C.-M., Bennett, C.F., and Chilton, F.H. 1991. Characterization of Co-A independent transacylase activity in U937 cells. Biochim. Biophys. Acta, 1081: 339-346.
188. Winkler, J.D., Fonteh, A.N., Sung, C.M., Heravi, J.D., Nixon, A.B., Chabot-Fletcher, M., Griswold, D., Marshall, L.A., and Chilton, F.H. 1995. Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators. J. Pharmacol. Exp. Ther. 274: 1338-1347.
189. 2: structure and function. Biochim. Biophys. Acta, 1488: 28-39.
190. 2 in canine myocardium. J. Biol. Chem. 260: 7295-7303.
191. 2. J. Biol. Chem. 271: 20 989 - 20 992.
192. 2. A novel mechanism underlying arachidonic acid mobilization. J. Biol. Chem. 272: 1522-1526.
193. 2. J. Exp. Med. 196: 349-357.
194. Yamashita, A., Sugiura, T., and Waku, K. 1997. Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells. J. Biochem. (Tokyo), 122: 1-16.
195. 2 and characterization of arachidonic acid-containing choline glycerophospholipids in hepatic peroxisomes. FEBS Lett. 546: 247-250.
196. 2 in thrombin-induced arachidonic acid release and growth in vascular smooth muscle cells. J. Biol. Chem. 278: 43 831 - 43 877.
197. Zhou, L., and Nilsson, A. 2001. Sources of eicosanoid precursor fatty acid pools in tissues. J. Lipid Res. 42: 1521-1542.
198. Zimmerman, G.A., McIntyre, T.M., Prescott, S.M., and Stafforini, D.M. 2002. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit. Care Med. 30: S294-S301.